Page last updated: 2024-10-29

ketamine and Hyaline Membrane Disease

ketamine has been researched along with Hyaline Membrane Disease in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salik, I1
Kubal, K1
Barst, S1

Other Studies

1 other study available for ketamine and Hyaline Membrane Disease

ArticleYear
Anesthetic Implications of a Patient With Kniest Dysplasia and Mitochondrial Disease: A Case Report.
    A&A practice, 2019, Apr-15, Volume: 12, Issue:8

    Topics: Anesthesia; Anesthetics; Cataract Extraction; Child; Cleft Palate; Collagen Diseases; Dexmedetomidin

2019